Source: Pixabay

Evonik rises against the market – BASF falls after fresh takeover reports

Shares in Evonik Industries AG gained 2% this week to EUR 21.60. The speciality chemicals group briefly reached EUR 22.52 on Wednesday, its highest level since March 2025. Its market capitalisation stands at around EUR 10.15 billion. While the broader German market recently declined, Evonik benefited from fresh reports of a possible takeover approach by BASF.

The Essen-based company produces speciality chemicals for numerous industries. These include additives for coatings and plastics, ingredients for cosmetics and pharmaceuticals, and products for animal nutrition. On Tuesday, however, the focus was on whether BASF might step up its takeover plans again. Speculation about a merger had already moved Evonik shares in recent weeks.

According to Bloomberg, BASF was preparing another attempt. A new offer could therefore follow within days. Reuters reported, citing people familiar with the matter, that BASF was considering additional concessions to secure support for the transaction. The focus was on commitments regarding production sites, jobs and training. However, this did not yet constitute the announcement of a new binding takeover offer.

According to the reports, BASF had approached the state government of North Rhine-Westphalia and the RAG-Stiftung, Evonik’s largest shareholder. Both play a crucial role in a potential takeover. BASF and the foundation declined to comment. The state government referred to its existing position that Evonik’s independence should be protected. Whether additional commitments would be sufficient initially remained unclear.

Shares in BASF SE meanwhile fell by more than 5.25% to around EUR 51.50. The two chemical stocks thus performed markedly differently. Back in October, BASF had raised the proposed takeover price to EUR 24 per Evonik share, implying a valuation of around EUR 11.18 billion. Evonik rejected the approach. A subsequent meeting between the companies’ management teams initially also failed to produce an agreement on further negotiations. Evonik’s closing share price remained around 8% below the proposed price.

On the operational front, Evonik had already presented more encouraging quarterly figures on November 3. Revenue rose by 13% to EUR 3.83 billion in the third quarter, while adjusted EBITDA increased by 40% to EUR 629 million. The corresponding margin improved from 13.2% to 16.4%. Higher selling prices were the key driver. Nevertheless, charges arising from the group’s restructuring pushed the net result down to a loss of EUR 53 million. For 2026, Evonik expected adjusted EBITDA in the upper half of the EUR 2.0 to 2.2 billion range.

From a technical analysis perspective, the short-term rise above EUR 22 strengthened the recovery. Monday’s closing price of EUR 21.20 is an initial downside reference level. Above that, the takeover price proposed so far of EUR 24 remains an important benchmark. The deciding factor is likely to be whether the reported preparations actually result in a new offer and whether the key parties agree to it.

Tungsten monopoly in the crosshairs: Almonty pushes for Western self-sufficiency

The geopolitical confrontation between Washington and Beijing, together with looming trade barriers, is forcing Western industrial and defence sectors to radically restructure their supply chains, particularly for raw materials with critical supply risks. As China continues to control more than 80% of global mining and refining of the key metal tungsten, self-sufficient mining projects outside the Chinese sphere of influence are gaining strategic, but also existential, relevance. 

In this market environment, Almonty Industries has positioned itself as a central pillar of supply security for Western nations through the commissioning of the Sangdong mine in South Korea. Its economic foundation is a binding offtake agreement with Plansee subsidiary Global Tungsten & Powders for 4.41 million metric tonne units (MTU) over 21 years, guaranteeing a predictable minimum annual offtake of 210,000 units. With the European benchmark price for ammonium paratungstate (APT) recently at around USD 2,950 per MTU, the group benefits from strong margins.

The operational base is being specifically strengthened through the company’s global diversification initiatives in Europe, Africa and North America. At the Los Santos site in Spain, the company processes historical ore stockpiles. An offtake agreement with Sandvik subsidiary Wolfram Bergbau und Hütten AG (WBH) provides for the recovery of 1,720 tonnes of tungsten trioxide, with capital expenditure of around USD 4 million. Contractual pre-financing of USD 3 million by WBH already covers 74% of the project. Commercial start-up is envisaged for the first quarter of 2027. The value chain is supplemented by a 75%-owned joint venture in Rwanda with an annual capacity of 1,300 tonnes of ore. Added to this is the Gentung Browns Lake development project in the USA. The recent appointment of two independent directors also underpins the planned secondary listing on the Seoul stock exchange. This is likely to increase access to South Korean investment capital significantly.

Despite the significant improvement in third-quarter earnings, the transformation is not proceeding without friction. Delays at Sangdong and noticeable cost pressure have prompted renowned research firms such as Stifel and B. Riley to moderately lower their price targets to USD 18. However, both firms continue to reaffirm their Buy recommendations. By contrast, experts such as Oppenheimer, with a price target of USD 19, and Sphene Capital, with USD 22.40, see substantial upside potential of around 200% from the current price of USD 7.81. For long-term market participants, Almonty therefore represents an interesting entry point into the Western tungsten value chain.

Deutsche Bank slumps – Data leak sparks fresh reputational concerns

Shares in Deutsche Bank AG fell by around 9.6% to EUR 30 from the start of the week, but recovered slightly on Thursday. This made Germany’s most important bank one of the DAX’s biggest losers. The trigger was new media reports about past business relationships and possible weaknesses in internal controls.

The reports were based on an extensive collection of internal records. According to the media outlets involved, more than 200 journalists analysed around 15 million documents, including emails and meeting minutes. The media outlets reporting on the matter included Der Spiegel, the Financial Times, the New York Times and Le Monde. The focus included past business relationships with Jeffrey Epstein, Donald Trump and Russian oligarchs. The reports once again raised questions about the bank’s handling of sensitive client relationships and the effectiveness of its control mechanisms. This created uncertainty among investors about what further information from the records might become public. The share price decline shows how sensitively the stock reacted to new reputational risks. 

In its statement, Deutsche Bank pointed out that the matters raised date back many years and, in some cases, as much as two decades. Since then, the bank has significantly improved its controls. Given the historical nature of the events, the bank does not expect any significant financial impact, if any. Supervisory Board Chairman Alexander Wynaendts also backed CEO Christian Sewing, who has led the bank since 2018. Two different assessments thus clashed on the stock market. While the bank characterised the events as a largely resolved part of its past, the share price decline reflected fresh doubts among investors. No specific additional charges running into billions had initially been confirmed. Nevertheless, further publications could prolong the public debate and undermine confidence in the progress made on compliance and risk control. The key question remains whether new information goes beyond already known legacy issues.

From a technical perspective, the decline worsened the short-term picture. The shares fell sharply to EUR 30. The area around EUR 30 is initially a support level to watch. A return above EUR 32–33 would initially ease selling pressure and stabilise the share price. A recovery is likely to hinge on whether the bank can convincingly contain the fresh reputational concerns.

Conclusion

Evonik shares rose to a recent EUR 21.60, supported by more encouraging operating figures and new takeover reports relating to BASF. However, there is still no binding offer. Almonty Industries is building a Western tungsten supply with Sangdong and other projects. Deutsche Bank fell back to around EUR 30 after media reports about historical business relationships sparked fresh doubts about controls, compliance and reputation.


Conflict of interest

Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as “Relevant Persons”) may hold shares or other financial instruments of the aforementioned companies in the future or may bet on rising or falling prices and thus a conflict of interest may arise in the future. The Relevant Persons reserve the right to buy or sell shares or other financial instruments of the Company at any time (hereinafter each a “Transaction”). Transactions may, under certain circumstances, influence the respective price of the shares or other financial instruments of the Company.

In addition, Apaton Finance GmbH is active in the context of the preparation and publication of the reporting in paid contractual relationships.

For this reason, there is a concrete conflict of interest.

The above information on existing conflicts of interest applies to all types and forms of publication used by Apaton Finance GmbH for publications on companies.

Risk notice

Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and the like on news.financial. These contents are exclusively for the information of the readers and do not represent any call to action or recommendations, neither explicitly nor implicitly they are to be understood as an assurance of possible price developments. The contents do not replace individual expert investment advice and do not constitute an offer to sell the discussed share(s) or other financial instruments, nor an invitation to buy or sell such.

The content is expressly not a financial analysis, but a journalistic or advertising text. Readers or users who make investment decisions or carry out transactions on the basis of the information provided here do so entirely at their own risk. No contractual relationship is established between Apaton Finance GmbH and its readers or the users of its offers, as our information only refers to the company and not to the investment decision of the reader or user.

The acquisition of financial instruments involves high risks, which can lead to the total loss of the invested capital. The information published by Apaton Finance GmbH and its authors is based on careful research. Nevertheless, no liability is assumed for financial losses or a content-related guarantee for the topicality, correctness, appropriateness and completeness of the content provided here. Please also note our Terms of use.


Stockhouse does not provide investment advice or recommendations. All investment decisions should be made based on your own research and consultation with a registered investment professional. The issuer is solely responsible for the accuracy of the information contained herein. For full disclaimer information, please click here.

More From The Market Online

Shock at Deutz! Opportunity at Evotec? Buy recommendation for Desert Gold!

Created and Published on Behalf of Desert Gold Ventures Inc.Shock at Deutz! After the share price plunged from over EUR 13, a short-seller attack…

Anthropic IPO and the energy hunger of AI and HighTech – Micron, Infineon, Anthropic and NU E Power in focus

Created and published on behalf of NU E Power Corp. Sharp declines, then a trillion-dollar IPO! Following the sharp correction on growth stock markets,…

Volatile markets: Opportunities in Micron Technology, Strategic Resources and Mercedes-Benz

Anthropic's stock market flotation is currently overshadowing everything in the markets and even appears to be pushing the scandal surrounding Nvidia CEO Jensen Huang…

Merck KGaA, BioNxt Solutions and Novartis – A billion-dollar market is being reshaped

Multiple sclerosis has long been a billion-dollar market. But as established drugs come under pressure from expiring patents, new therapeutic approaches are advancing through…